Neuberger Berman Group LLC Ocugen, Inc. Call Options Transaction History
Neuberger Berman Group LLC
- $124 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OCGN
# of Institutions
108Shares Held
64.3MCall Options Held
604KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$27.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$22.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$7.79 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$6.4 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$5.37 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $334M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...